title: The evolving paradigm of cancer risk related to cyclophosphamide therapy in granulomatosis with polyangiitis.
authors.affiliation: Nephrology Unit, University Hospital of Parma, Parma and Nephrology, Dialysis and Transplant Unit, University of Pavia, IRCCS Policlinico San Matteo, Pavia, Italy.
authors.forename: Marta
authors.initials: M
authors.lastname: Calatroni
authors.affiliation: Nephrology Unit, University Hospital of Parma, Parma and.
authors.forename: Carlo
authors.initials: C
authors.lastname: Buzio
authors.affiliation: Nephrology Unit, University Hospital of Parma, Parma and augusto.vaglio@virgilio.it.
authors.forename: Augusto
authors.initials: A
authors.lastname: Vaglio
mesh_terms: D003520:Cyclophosphamide / Q000009:adverse effects* / Q000627:therapeutic use*; D005260:Female; D014890:Granulomatosis with Polyangiitis / Q000188:drug therapy*; D006801:Humans; D008297:Male; D012878:Skin Neoplasms / Q000453:epidemiology*; D001749:Urinary Bladder Neoplasms / Q000453:epidemiology*
chemical_list: D003520:Cyclophosphamide